<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33315714</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Crohn's Disease after Proctocolectomy and IPAA for Ulcerative Colitis.</ArticleTitle><Pagination><StartPage>217</StartPage><EndPage>224</EndPage><MedlinePgn>217-224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000001721</ELocationID><Abstract><AbstractText Label="BACKGROUND">Proctocolectomy with IPAA is considered curative for ulcerative colitis. However, signs of Crohn's disease can develop postoperatively in some cases.</AbstractText><AbstractText Label="OBJECTIVE">Our aim was to document the postoperative diagnosis of Crohn's disease, to identify potential preoperative predictive factors, and to review the evolution of patients on treatment.</AbstractText><AbstractText Label="DESIGN">This is a retrospective cohort study.</AbstractText><AbstractText Label="SETTINGS">This study was conducted at a tertiary care center in Montreal, Canada.</AbstractText><AbstractText Label="PATIENTS">A total of 301 patients underwent an IPAA for ulcerative colitis between 1985 and 2014.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">The primary outcome was the cumulative incidence of the postoperative diagnosis of Crohn's disease.</AbstractText><AbstractText Label="RESULTS">During a median follow-up of 68 months, Crohn's disease was diagnosed at a median time of 77 months (8-270) in 38 patients (12.6%). The cumulative incidence of Crohn's disease was 7.5% at 5 years postoperatively and gradually increased to 17.7% and 33.0% at 10 and 20 years. The following predictive factors for Crohn's disease were observed on univariate analysis: current tobacco smoking at surgery (HR 3.56 (95% CI, 1.54-8.22)), suspicion of indeterminate colitis (HR 3.50 (95% CI, 1.69-7.24)), presence of mouth ulcers before surgery (HR 2.16 (95% CI, 1.03-4.53)), and age at diagnosis of ulcerative colitis (HR 0.94 (95% CI, 0.90-0.97)). Suspicion of indeterminate colitis (HR 3.18 (95% CI 1.46-6.93); p = 0.004) and age at diagnosis (HR 0.95 (95% CI, 0.91-0.99); p = 0.018) remained statistically significant on multivariate analysis. Postoperative inflammatory disease was controlled by medical therapy in most patients. Removal of the pouch was necessary in 16% of patients with Crohn's disease.</AbstractText><AbstractText Label="LIMITATIONS">This was a retrospective single-center study.</AbstractText><AbstractText Label="CONCLUSIONS">Diagnosis of Crohn's disease can occur at a distance from surgery with an increasing cumulative incidence over time. Preoperative predictive factors are few and should not determine candidacy for surgery. Therapeutic options are identical to those available for treatment of typical Crohn's disease and allow a favorable evolution in most patients. See Video Abstract at http://links.lww.com/DCR/B372.</AbstractText><AbstractText Label="BROTE DE CROHN DESPUS DE UNA PROCTOCOLECTOMA CON ANASTOMOSIS DE RESERVORIO LEOANAL EN CASOS DE COLITIS ULCEROSA">ANTECEDENTES:La proctocolectom&#xed;a con reservorio ileo-anal se considera curativa para la colitis ulcerosa. Sin embargo, signos de enfermedad de Crohn pueden desarrollarse despu&#xe9;s de la operaci&#xf3;n en algunos casos.OBJETIVO:Nuestro objetivo fue documentar el diagn&#xf3;stico postoperatorio de la enfermedad de Crohn, identificar posibles factores predictivos preoperatorios y revisar la evoluci&#xf3;n de los pacientes con tratamiento.DISE&#xd1;O:Estudio retrospectivo de cohortes.AJUSTES:Centro de atenci&#xf3;n terciaria en Montreal, Canad&#xe1;.PACIENTES:301 pacientes portadores de un reservorio &#xed;leo-anal realizados por colitis ulcerosa entre 1985 y 2014.PRINCIPALES MEDIDAS DE RESULTADO:Acumulaci&#xf3;n de la incidencia en el diagn&#xf3;stico postoperatorio de enfermedad de Crohn.RESULTADOS:Durante una media de 68 meses de seguimiento, la enfermedad de Crohn fu&#xe9; diagnosticada en un tiempo medio de 77 meses (8-270) en 38 pacientes (12,6%). La acumulaci&#xf3;n de incidencia de la enfermedad de Crohn fue del 7,5% a los 5 a&#xf1;os despu&#xe9;s de la operaci&#xf3;n y aument&#xf3; gradualmente a 17,7 y 33,0% a los 10 y 20 a&#xf1;os. Los siguientes factores predictivos para la enfermedad de Crohn se observaron en el an&#xe1;lisis univariado: tabaquismo activo al momento de la cirug&#xed;a (cociente de riesgo (HR) 3.56 (intervalo de confianza del 95% (IC) 1.54-8.22)), sospecha de colitis indeterminada (HR 3.50 (IC del 95% 1.69-7.24)), presencia de &#xfa;lceras en la boca antes de la cirug&#xed;a (HR 2.16 (IC 95% 1.03-4.53)) y edad al diagn&#xf3;stico de colitis ulcerosa (HR 0.94 (IC 95% 0.90-0.97)). La sospecha de colitis indeterminada (HR 3.18 (IC 95% 1.46-6.93), p = 0.004) y la edad al momento del diagn&#xf3;stico (HR 0.95 (IC 95% 0.91-0.99), p = 0.018) permanecieron estad&#xed;sticamente significativos en el an&#xe1;lisis multivariado. La reacci&#xf3;n inflamatoria intestinal postoperatoria fue controlada con tratamiento m&#xe9;dico en la mayor&#xed;a de los pacientes. El retiro del reservorio &#xed;leo-anal fue necesario en 16% de los pacientes con enfermedad de Crohn.LIMITACIONES:Estudio retrospectivo de centro &#xfa;nico.CONCLUSIONES:El diagn&#xf3;stico de la enfermedad de Crohn puede ocurrir a distancia de la cirug&#xed;a con la acumulaci&#xf3;n de incidencia creciente con el tiempo. Los factores predictivos preo-peratorios son pocos y no pueden determinar la candidatura para la cirug&#xed;a. Las opciones terap&#xe9;uticas son id&#xe9;nticas a las disponibles para el tratamiento de la enfermedad de Crohn t&#xed;pica y permiten una evoluci&#xf3;n favorable en la mayor&#xed;a de los pacientes. Consulte Video Resumen en http://links.lww.com/DCR/B372. (Traducci&#xf3;n-Dr. Xavier Delgadillo).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hercun</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#xf4;t&#xe9;-Daigneault</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lahaie</LastName><ForeName>Raymond G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richard</LastName><ForeName>Carole</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Digestive Surgery, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wassef</LastName><ForeName>Rams&#xe8;s</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Digestive Surgery, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poitras</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Centre hospitalier de l'Universit&#xe9; de Montr&#xe9;al, Montreal, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Dis Colon Rectum. 2021 Feb 1;64(2):143-144. doi: 10.1097/DCR.0000000000001780.</RefSource><PMID Version="1">33315705</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="N">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003424" MajorTopicYN="N">Crohn Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016737" MajorTopicYN="Y">Proctocolectomy, Restorative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>14</Day><Hour>17</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33315714</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000001721</ArticleId><ArticleId IdType="pii">00003453-202102000-00013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222:120&#x2013;127.</Citation></Reference><Reference><Citation>Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg. 1998;85:800&#x2013;803.</Citation></Reference><Reference><Citation>Brown CJ, Maclean AR, Cohen Z, Macrae HM, O&#x2019;Connor BI, McLeod RS. Crohn&#x2019;s disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure. Dis Colon Rectum. 2005;48:1542&#x2013;1549.</Citation></Reference><Reference><Citation>Reese GE, Lovegrove RE, Tilney HS, et al. The effect of Crohn&#x2019;s disease on outcomes after restorative proctocolectomy. Dis Colon Rectum. 2007;50:239&#x2013;250.</Citation></Reference><Reference><Citation>Le Q, Melmed G, Dubinsky M, et al. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn&#x2019;s disease. Inflamm Bowel Dis. 2013;19:30&#x2013;36.</Citation></Reference><Reference><Citation>Shen B. Diagnosis and management of postoperative ileal pouch disorders. Clin Colon Rectal Surg. 2010;23:259&#x2013;268.</Citation></Reference><Reference><Citation>Melmed GY, Fleshner PR, Bardakcioglu O, et al. Family history and serology predict Crohn&#x2019;s disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2008;51:100&#x2013;108.</Citation></Reference><Reference><Citation>Murrell ZA, Melmed GY, Ippoliti A, et al. A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis. Dis Colon Rectum. 2009;52:872&#x2013;878.</Citation></Reference><Reference><Citation>Alexander F, Sarigol S, DiFiore J, et al. Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. J Pediatr Surg. 2003;38:78&#x2013;82.</Citation></Reference><Reference><Citation>Dayton MT, Larsen KR, Christiansen DD. Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis. Arch Surg. 2002;137:690&#x2013;694.</Citation></Reference><Reference><Citation>Delaney CP, Remzi FH, Gramlich T, Dadvand B, Fazio VW. Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Ann Surg. 2002;236:43&#x2013;48.</Citation></Reference><Reference><Citation>Shen B, Fazio VW, Remzi FH, et al. Risk factors for clinical phenotypes of Crohn&#x2019;s disease of the ileal pouch. Am J Gastroenterol. 2006;101:2760&#x2013;2768.</Citation></Reference><Reference><Citation>Tekkis PP, Heriot AG, Smith O, Smith JJ, Windsor AC, Nicholls RJ. Long-term outcomes of restorative proctocolectomy for Crohn&#x2019;s disease and indeterminate colitis. Colorectal Dis. 2005;7:218&#x2013;223.</Citation></Reference><Reference><Citation>Marcello PW, Schoetz DJ Jr, Roberts PL, et al. Evolutionary changes in the pathologic diagnosis after the ileoanal pouch procedure. Dis Colon Rectum. 1997;40:263&#x2013;269.</Citation></Reference><Reference><Citation>Yu CS, Pemberton JH, Larson D. Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Dis Colon Rectum. 2000;43:1487&#x2013;1496.</Citation></Reference><Reference><Citation>Melton GB, Kiran RP, Fazio VW, et al. Do preoperative factors predict subsequent diagnosis of Crohn&#x2019;s disease after ileal pouch-anal anastomosis for ulcerative or indeterminate colitis? Colorectal Dis. 2010;12:1026&#x2013;1032.</Citation></Reference><Reference><Citation>Kjaer MD, Kjeldsen J, Qvist N. Poor outcomes of complicated pouch-related fistulas after ileal pouch-anal anastomosis surgery. Scand J Surg. 2016;105:163&#x2013;167.</Citation></Reference><Reference><Citation>Melton GB, Fazio VW, Kiran RP, et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn&#x2019;s disease: pouch retention and implications of delayed diagnosis. Ann Surg. 2008;248:608&#x2013;616.</Citation></Reference><Reference><Citation>Melmed GY, Elashoff R, Chen GC, et al. Predicting a change in diagnosis from ulcerative colitis to Crohn&#x2019;s disease: a nested, case-control study. Clin Gastroenterol Hepatol. 2007;5:602&#x2013;608.</Citation></Reference><Reference><Citation>Colombel JF, Ricart E, Loftus EV Jr, et al. Management of Crohn&#x2019;s disease of the ileoanal pouch with infliximab. Am J Gastroenterol. 2003;98:2239&#x2013;2244.</Citation></Reference><Reference><Citation>Shen B, Remzi FH, Lavery IC, et al. Administration of adalimumab in the treatment of Crohn&#x2019;s disease of the ileal pouch. Aliment Pharmacol Ther. 2009;29:519&#x2013;526.</Citation></Reference><Reference><Citation>Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg. 2007;94:333&#x2013;340.</Citation></Reference><Reference><Citation>Barnes EL, Kochar B, Jessup HR, Herfarth HH. The incidence and definition of Crohn&#x2019;s disease of the pouch: a systematic review and meta-analysis. Inflamm Bowel Dis. 2019;25:1474&#x2013;1480.</Citation></Reference><Reference><Citation>Truta B, Li DX, Mahadevan U, et al. Serologic markers associated with development of Crohn&#x2019;s disease after ileal pouch anal anastomosis for ulcerative colitis. Dig Dis Sci. 2014;59:135&#x2013;145.</Citation></Reference><Reference><Citation>Zaghiyan K, Kami&#x144;ski JP, Barmparas G, Fleshner P. De novo Crohn&#x2019;s disease after ileal pouch-anal anastomosis for ulcerative colitis and inflammatory bowel disease unclassified: long-term follow-up of a prospective inflammatory bowel disease registry. Am Surg. 2016;82:977&#x2013;981.</Citation></Reference><Reference><Citation>Shannon A, Eng K, Kay M, et al. Long-term follow up of ileal pouch anal anastomosis in a large cohort of pediatric and young adult patients with ulcerative colitis. J Pediatr Surg. 2016;51:1181&#x2013;1186.</Citation></Reference><Reference><Citation>Fazio VW, Tekkis PP, Remzi F, et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg. 2003;238:605&#x2013;614.</Citation></Reference><Reference><Citation>Polites SF, Potter DD, Moir CR, et al. Long-term outcomes of ileal pouch-anal anastomosis for pediatric chronic ulcerative colitis. J Pediatr Surg. 2015;50:1625&#x2013;1629.</Citation></Reference><Reference><Citation>Lorenzo G, Maurizio C, Maria LP, et al. Ileal pouch-anal anastomosis 20 years later: is it still a good surgical option for patients with ulcerative colitis? Int J Colorectal Dis. 2016;31:1835&#x2013;1843.</Citation></Reference><Reference><Citation>Shen B. Crohn&#x2019;s disease of the ileal pouch: reality, diagnosis, and management. Inflamm Bowel Dis. 2009;15:284&#x2013;294.</Citation></Reference><Reference><Citation>Moore C, Jakate S, Keshavarzian A. An esophagogastroduodenal Crohn&#x2019;s-like disease in a long-standing pan-ulcerative colitis patient. Case Rep Gastrointest Med. 2014;2014:464139.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30067718</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2444-054X</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>4</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>Cirugia y cirujanos</Title><ISOAbbreviation>Cir Cir</ISOAbbreviation></Journal><ArticleTitle>[Calidad de vida en adultos con cicatrices queloides].</ArticleTitle><Pagination><StartPage>321</StartPage><EndPage>326</EndPage><MedlinePgn>321-326</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/CIRU.M18000049</ELocationID><Abstract><AbstractText Label="INTRODUCCI&#xd3;N" NlmCategory="UNASSIGNED">Las cicatrices queloides afectan hasta el 16% de la poblaci&#xf3;n hispana y pueden causar un deterioro en la calidad de vida. La mayor&#xed;a de los estudios previos han estudiado pacientes con cicatrices hipertr&#xf3;ficas secundarias a quemaduras.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Determinar la calidad de vida en adultos con cicatrices queloides que acuden a un centro dermatol&#xf3;gico.</AbstractText><AbstractText Label="M&#xc9;TODO" NlmCategory="UNASSIGNED">Se realiz&#xf3; un estudio transversal anal&#xed;tico en el Centro Dermatol&#xf3;gico Dr. Ladislao de la Pascua, en adultos con diagn&#xf3;stico de cicatrices queloides. Se midi&#xf3; la calidad de vida mediante el instrumento DLQI (Dermatology Life Quality Index) y se estudiaron las siguientes variables cl&#xed;nicas: edad, sexo, tiempo de evoluci&#xf3;n, tama&#xf1;o de la cicatriz, n&#xfa;mero de cicatrices y topograf&#xed;a afectada. Se aplic&#xf3; el cuestionario de Beck para el tamizaje de la depresi&#xf3;n.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">Se reclutaron 106 adultos con cicatrices queloides (61% hombres y 39% mujeres), con una mediana de edad de 26 a&#xf1;os (rango intercuartilar: &#xb1;18 a&#xf1;os). El puntaje promedio del DLQI fue de 5.58 (desviaci&#xf3;n est&#xe1;ndar [DE]: &#xb1; 5.528), con un m&#xe1;ximo obtenido de 22 puntos; dicho puntaje se interpreta como un deterioro m&#xed;nimo de la calidad de vida. La dimensi&#xf3;n que m&#xe1;s contribuy&#xf3; al total del puntaje fue la de s&#xed;ntomas y sentimientos, con el 50.36%. El n&#xfa;mero de cicatrices y la edad se asociaron directamente con el puntaje del DLQI. El puntaje promedio obtenido con el cuestionario de Beck fue de 6.45 (DE: &#xb1; 6.46 puntos) y se correlacion&#xf3; con el puntaje del DLQI.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">Las cicatrices queloides tienen un efecto negativo m&#xed;nimo en la calidad de vida. Dicho efecto se asoci&#xf3; al autorreporte de s&#xed;ntomas depresivos; sin embargo, los resultados de este estudio no permiten atribuirle una relaci&#xf3;n casual. Se recomienda aplicar el cuestionario de calidad de vida en adultos j&#xf3;venes con cicatrices.</AbstractText><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Keloid scars affect up to 16% of the Hispanic population and may cause deterioration in the quality of life. Most of the previous studies have focused on patients with hypertrophic scars secondary to burns.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the quality of life in adults with keloid scars that go to a dermatological center.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An analytical cross-sectional study was carried out at Centro Dermatol&#xf3;gico Dr. Ladislao de la Pascua in adults with a diagnosis of keloid scars. The quality of life was measured using the Dermatology Life Quality Index (DLQI) and the following clinical variables were studied: age, sex, evolution time, scar size, number of scars and affected topography. The Beck questionnaire for depression was also applied.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">106 adults with keloid scars were recruited, 61% men and 39% women, with a median age of 26 years (interquartile range: &#xb1; 18 years). The average score of the DLQI was 5.58 (standard deviation [SD]: &#xb1; 5.528), with a maximum obtained of 22 points, this score is interpreted as a minimum or small deterioration of the quality of life. The dimension that contributed most to the total score was symptoms and feelings, with 50.36%. The number of scars and age were directly associated with the DLQI score. The average score obtained with the Beck questionnaire was: 6.45 (SD: &#xb1; 6.46 points) and it correlates with the DLQI score.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Keloid scars have a minimal negative effect on the quality of life of young adults. This effect was associated with the self-report of depressive symptoms; however, the results of this study do not allow to attribute a causal relationship. It is recommended to apply the quality of life questionnaire in young adults with scars.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2018 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morales-S&#xe1;nchez</LastName><ForeName>Martha A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n, Centro Dermatol&#xf3;gico Dr. Ladislao de la Pascua, Servicios de Salud P&#xfa;blica, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores-Ruvalcaba</LastName><ForeName>Christian N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n, Centro Dermatol&#xf3;gico Dr. Ladislao de la Pascua, Servicios de Salud P&#xfa;blica, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peralta-Pedrero</LastName><ForeName>Mar&#xed;a L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n, Centro Dermatol&#xf3;gico Dr. Ladislao de la Pascua, Servicios de Salud P&#xfa;blica, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villafranca-Dugelby</LastName><ForeName>Andrea De</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n, Centro Dermatol&#xf3;gico Dr. Ladislao de la Pascua, Servicios de Salud P&#xfa;blica, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>Ferm&#xed;n Jurado-Santa</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n, Centro Dermatol&#xf3;gico Dr. Ladislao de la Pascua, Servicios de Salud P&#xfa;blica, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Quality of life in adults with keloid scars.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Cir Cir</MedlineTA><NlmUniqueID>0372736</NlmUniqueID><ISSNLinking>0009-7411</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007627" MajorTopicYN="Y">Keloid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adultos</Keyword><Keyword MajorTopicYN="N">Adults</Keyword><Keyword MajorTopicYN="N">Calidad de vida</Keyword><Keyword MajorTopicYN="N">Cicatrix</Keyword><Keyword MajorTopicYN="N">Cicatriz</Keyword><Keyword MajorTopicYN="N">Cicatriz queloide</Keyword><Keyword MajorTopicYN="N">Keloid scar</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Scar</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30067718</ArticleId><ArticleId IdType="doi">10.24875/CIRU.M18000049</ArticleId><ArticleId IdType="pii">j86/4/321</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>